News for hackers. Stuff that matters.

A comment on Humira’s Drug Formula: Start at a High Price, Go Higher. Parent comment

Re:Humira’s Drug Formula: Start at a High Price, Go Higher by cnewey on Monday January 08, 2018 @08:30AM (#16096540)
Perhaps the NHS shouldn't - not paying for Humira would essentially obliterate AbbVie's UK market, which would make a considerable dent in their profits... I guess that would probably make them re-think their pricing structure!

However, presumably the treatment is "worth" the NHS paying for it - even if it is massively overpriced. I can't really pass comment on their medication choices.

[ Parent | on HN ]

There are no comments on this comment yet.